Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Baseline demographic and clinical characteristics of the patients*.

More »

Table 1 Expand

Figure 1.

Adjusted mean changes (±SE) in HbA1c levels from baseline to week 24.

More »

Figure 1 Expand

Table 2.

Effects on various gluco-metabolic and lipid parameters of lobeglitazone as compared with placebo from baseline to 24 weeks.

More »

Table 2 Expand

Table 3.

Summary of clinical adverse events of the patients.

More »

Table 3 Expand